Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Querfeld

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Current Opinion in Oncology|December 4, 2015
Tumor microenvironment in mycosis fungoides and Sézary syndromeBelen Rubio Gonzalez, Jasmine Zain, Steven T Rosen, et al.
Advances in Therapy|January 19, 2023
Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World SettingsUlrike Wehkamp, Marco Ardigò, Evangelia Papadavid, et al.
Journal of the American Academy of Dermatology|August 1, 2021
Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension studyChristiane Querfeld, Youn H Kim, Joan Guitart, et al.
JAMA Dermatology|July 17, 2014
Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndromeSarah I Jawed, Klaus Busam, Xuan Wang, et al.
Acta Dermato-Venereologica|February 7, 2023
Prior Bexarotene or Phototherapy Does Not Affect Response to Chlormethine Gel: Post Hoc Analysis of a Pivotal TrialChalid Assaf, Christiane Querfeld, Marta Scandurra, et al.
Journal of the American Academy of Dermatology|January 21, 2014
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directionsSarah I Jawed, Patricia L Myskowski, Steven Horwitz, et al.
Frontiers in Medicine|July 19, 2021
A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)-A Retrospective Cohort StudyChristiane Querfeld, Theresa Pacheco, Bradley Haverkos, et al.
JAMA Dermatology|September 23, 2016
Cutaneous Gamma-Delta T-Cell Lymphoma Successfully Treated With Brentuximab VedotinBelen Rubio-Gonzalez, Jasmine Zain, Lino Garcia, et al.
The British Journal of Dermatology|January 29, 2024
Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort studyNicholas A Trum, Lu Chen, Jasmine Zain, et al.
Dermatologic Clinics|October 5, 2015
Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary SyndromePooja Virmani, Jasmine Zain, Steven T Rosen, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Current Opinion in Oncology|December 4, 2015
Tumor microenvironment in mycosis fungoides and Sézary syndromeBelen Rubio Gonzalez, Jasmine Zain, Steven T Rosen, et al.
Advances in Therapy|January 19, 2023
Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World SettingsUlrike Wehkamp, Marco Ardigò, Evangelia Papadavid, et al.
Journal of the American Academy of Dermatology|August 1, 2021
Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension studyChristiane Querfeld, Youn H Kim, Joan Guitart, et al.
JAMA Dermatology|July 17, 2014
Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndromeSarah I Jawed, Klaus Busam, Xuan Wang, et al.
Acta Dermato-Venereologica|February 7, 2023
Prior Bexarotene or Phototherapy Does Not Affect Response to Chlormethine Gel: Post Hoc Analysis of a Pivotal TrialChalid Assaf, Christiane Querfeld, Marta Scandurra, et al.
Journal of the American Academy of Dermatology|January 21, 2014
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directionsSarah I Jawed, Patricia L Myskowski, Steven Horwitz, et al.
Frontiers in Medicine|July 19, 2021
A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)-A Retrospective Cohort StudyChristiane Querfeld, Theresa Pacheco, Bradley Haverkos, et al.
JAMA Dermatology|September 23, 2016
Cutaneous Gamma-Delta T-Cell Lymphoma Successfully Treated With Brentuximab VedotinBelen Rubio-Gonzalez, Jasmine Zain, Lino Garcia, et al.
The British Journal of Dermatology|January 29, 2024
Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort studyNicholas A Trum, Lu Chen, Jasmine Zain, et al.
Dermatologic Clinics|October 5, 2015
Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary SyndromePooja Virmani, Jasmine Zain, Steven T Rosen, et al.
Pageof 14